CP and ovarian cancer: Gathered evidence indicates that silencing LINC00176 could potentially inhibit ovarian cancer cell proliferation, migration and invasion while inducing apoptosis by down‐regulating CP via recruiting the BCL3 protein, the mechanism of which provides a novel understanding of ovarian cancer progression.